David Curiel
Founder bij Vectorlogics, Inc.
Profiel
David T.
Curiel is the founder of Vectorlogics, Inc. (founded in 1998) and holds the title of Director & Chief Scientific Officer since 2009.
Dr. Curiel is also the founder of Precision Virologics, Inc. Dr. Curiel's current job is as a Director at Provecs Medical GmbH.
Dr. Curiel's former job includes being the Director-Cancer Biology Division at the National Cancer Institute from 1985 to 1989 and a Principal at The University of Alabama.
Dr. Curiel's education includes a graduate degree from the University of Washington, an undergraduate degree from Emory University (conferred in 1982), and a doctorate degree from the University of Groningen (conferred in 2002).
Actieve functies van David Curiel
| Bedrijven | Functie | Begin |
|---|---|---|
Vectorlogics, Inc.
 Vectorlogics, Inc. BiotechnologyHealth Technology Vectorlogics, Inc. develops and commercialized vaccines for virus based cancer therapies and viral liver diseases. The company was founded by David T. Curiel in 1998 and is headquartered in Birmingham, AL. | Founder | 14-12-2009 |
Provecs Medical GmbH
 Provecs Medical GmbH BiotechnologyHealth Technology Provecs Medical GmbH develops therapeutic vaccines. It focuses in providing treatment options for patients with advanced cancer and infectious diseases. The company was founded by Frank Schnieders and Hansjoerg Forster in 2007 and is headquartered in Hamburg, Germany. | Director/Board Member | - |
Eerdere bekende functies van David Curiel
| Bedrijven | Functie | Einde |
|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01-01-1989 |
Precision Virologics, Inc.
 Precision Virologics, Inc. BiotechnologyHealth Technology Precision Virologics, Inc. develops biologically targeted vaccines for emerging infectious diseases. The company was founded by David T. Curiel in 2017 and is headquartered in Saint Louis, MO. | Founder | - |
| The University of Alabama | Corporate Officer/Principal | - |
Opleiding van David Curiel
| University of Washington | Graduate Degree |
| Emory University | Undergraduate Degree |
| University of Groningen | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Provecs Medical GmbH
Provecs Medical GmbH BiotechnologyHealth Technology Provecs Medical GmbH develops therapeutic vaccines. It focuses in providing treatment options for patients with advanced cancer and infectious diseases. The company was founded by Frank Schnieders and Hansjoerg Forster in 2007 and is headquartered in Hamburg, Germany. | Health Technology |
Vectorlogics, Inc.
Vectorlogics, Inc. BiotechnologyHealth Technology Vectorlogics, Inc. develops and commercialized vaccines for virus based cancer therapies and viral liver diseases. The company was founded by David T. Curiel in 1998 and is headquartered in Birmingham, AL. | Health Technology |
Precision Virologics, Inc.
Precision Virologics, Inc. BiotechnologyHealth Technology Precision Virologics, Inc. develops biologically targeted vaccines for emerging infectious diseases. The company was founded by David T. Curiel in 2017 and is headquartered in Saint Louis, MO. | Health Technology |
